Pharma News
Venus Concept Inc, a global leader in medical aesthetic technology, has successfully concluded its series of NEXThetics events across major cities in North America. These gatherings have grown significantly in popularity and attendance, with thousands of registrants participating, including a record-setting event in Houston, Texas on June 22, 2024. Dr. Cheryl Haseeb from Pura Medical […]
Antengene Corporation Limited (Antengene), a prominent global biopharmaceutical company, has announced a significant milestone: South Korea’s National Health Insurance Service (NHIS) has approved reimbursement for Xpovio (selinexor) starting July 1, 2024. This approval marks Xpovio’s inclusion in South Korea’s national reimbursed drugs list for treating adult patients with relapsed or refractory multiple myeloma (R/R MM).
Stalicla SA, a Swiss neuro precision biotech company specializing in precision medicine for neuropsychiatric and neurodevelopmental disorders, has announced the publication of a significant phase 1b study on STP1. This novel combination therapy is tailored for treating a specific subgroup of patients with autism spectrum disorder (ASD) known as ASD Phenotype 1 (ASD-Phen1). Published in
Pharmexcil, the Pharmaceuticals Export Promotion Council of India, is set to resume discussions with Russia’s SBER Bank in New Delhi by the end of June 2024. This meeting aims to tackle challenges faced by exporters and address issues related to the Rupee-Rouble trade arrangement, crucial for trade between India and Russia. Pharmexcil is urging its
Pharmexcil Resumes Talks with SBER Bank to Enhance India-Russia Trade Relations Read More »
The National Testing Agency (NTA) has initiated the online application process for the DHR-ICMR Non-Medical Fellowship for Ph.D 2024 – Biomedical Research Eligibility Test (BRET). This test aims to assess the eligibility of Indian national candidates for Junior Research Fellowships (JRF) under the Department of Health Research (DHR) and the Indian Council of Medical Research
Applications open for Biomedical Research Eligibility Test Read More »
Diabetes specialists in India are increasingly concerned about foot infections among diabetic patients, as these often lead to serious complications like lower limb amputations. Currently, about 15% of diabetics in India suffer from diabetic foot infections (DFI), which are commonly caused by bacteria like Pseudomonas, E. coli, and S. aureus. The recent guidelines from the
Indian diabetologists view US FDA’s recent guidance on diabetic foot infections timely Read More »
The All Kerala Chemists and Druggists Association (AKCDA) plans to approach District Magistrates and District Child Protection Units (DCPUs) to request an extension of the deadline for installing CCTV surveillance cameras in their shops. They also seek exemptions for small-scale traders with a daily turnover below Rs. 1,500, as well as shops located away from
AKCDA to seek extension of date for installing CCTV cameras in medical shops Read More »
In May 2024, the Production Linked Incentive (PLI) scheme for pharmaceuticals saw a notable investment of Rs. 940 crore, marking a 3.32% increase from April’s Rs. 28,328 crore to Rs. 29,268 crore. According to the Department of Pharmaceuticals (DoP), actual production surged by 12.3% in May to Rs. 1,61,209 crore, compared to Rs. 1,43,553 crore
PLI scheme for pharmaceuticals witnesses investment of Rs. 940 crore in May Read More »
At the Global Pharmaceutical Quality Summit-2024 in Mumbai, India’s Drugs Controller General, Rajeev Raghuvanshi, emphasized the urgent need for the pharmaceutical industry to bolster its quality management, documentation, and validation processes. He revealed that recent inspections had revealed alarming findings: approximately 36 percent of inspected pharma manufacturing units had to cease operations due to failing
